View Post

New Report Charts Dramatic Growth in the Global Clinical Trial Landscape for PD-1/L1 Immune Checkpoint Inhibitors

In Clinical Trials by Barbara Jacoby

From: cancerresearch.org 2,250 clinical trials are evaluating PD-1/L1 immune checkpoint inhibitors, an increase of 748 trials over the past year 1,716 trials are assessing regimens that combine PD-1/L1 immune checkpoints with other cancer therapies 240 drug targets are being evaluated in the current landscape, 75 more targets compared to a year ago Over 380,000 patient volunteers are required to fill …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In Clinical Trials by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

FREE Immunotherapy Patient Summit – Houston, Sat, December 8, 2018

In In The News by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, December 8, 2018 – 10:00 AM – 3:30 PM PDT Hosted at MD Anderson Cancer Center Dan L. Duncan Cancer Prevention Building, (CPB) – 8th Floor Conference Center 1155 Pressler Street Houston, TX 77030 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

FREE Immunotherapy Patient Summit – San Diego, Sat, October 27, 2018

In In The News by Barbara Jacoby

From: CANCER RESEARCH INSTITUTE Date and Time:  Sat, October 27, 2018 – 10:00 AM – 3:30 PM PDT Hosted at UC San Diego School of Medicine T. Denny Sanford Medical Education and Telemedicine Center 9500 Gilman Drive La Jolla, CA 92092 Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along with …

View Post

Register for Cancer Research Institute FREE Immunotherapy Patient Summits

In In The News, Uncategorized by Barbara Jacoby

Cancer Research Institute Immunotherapy Patient Summits are free half-day Saturday events that provide a forum for patients, caregivers, and advocates to meet together along with scientific and healthcare experts to learn more about how new breakthroughs in immunotherapy are changing standards of care for all cancers. In 2018, the Immunotherapy Patient Summit are upcoming to New York City, San Diego, …

View Post

FREE Immunotherapy Patient Summit – San Francisco

In In The News by Barbara Jacoby

By: Cancer Research Institute A FREE educational event will be held on June 30, 2018 at the Hilton San Francisco Union Square. Patients, caregivers, friends, family, and advocates are encouraged to attend this half-day Saturday event. People of all ages and cancer types are invited to attend. Learn about the basics of cancer immunotherapy, a highly promising new approach to cancer treatment. Medical experts along …

View Post

Immunotherapy is Here to Stay: Looking Back at this Year’s Breakthroughs

In In The News by Barbara Jacoby

By: Arthur N. Brodsky, Ph.D. From: cancerresearch.org This past year was a big one for immunotherapy—it was recognized as the ASCO Clinical Advance of the Year for the second year running—and for cancer patients. The constant pace of progress has been hard to follow at times, so to get you up to speed we’re closing out this amazing year with …

View Post

Cancer Patients and Caregivers Join Immunotherapy Experts in Five U.S. Cities to Discuss Latest Cancer Treatment Breakthroughs and Immunotherapy Clinical Trials

In In The News by Barbara Jacoby

Registration now open for free, half-day programs in San Francisco, Chicago, New York City, Houston, and Tampa The Cancer Research Institute (CRI), the world’s leading nonprofit organization dedicated exclusively to advancing scientific efforts to develop new and effective immunotherapies for all forms of cancer, announced today that its 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to …